These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31273855)

  • 1. Puerarin protects against high-fat high-sucrose diet-induced non-alcoholic fatty liver disease by modulating PARP-1/PI3K/AKT signaling pathway and facilitating mitochondrial homeostasis.
    Wang S; Yang FJ; Shang LC; Zhang YH; Zhou Y; Shi XL
    Phytother Res; 2019 Sep; 33(9):2347-2359. PubMed ID: 31273855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
    Mukhopadhyay P; Horváth B; Rajesh M; Varga ZV; Gariani K; Ryu D; Cao Z; Holovac E; Park O; Zhou Z; Xu MJ; Wang W; Godlewski G; Paloczi J; Nemeth BT; Persidsky Y; Liaudet L; Haskó G; Bai P; Boulares AH; Auwerx J; Gao B; Pacher P
    J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease.
    Gariani K; Ryu D; Menzies KJ; Yi HS; Stein S; Zhang H; Perino A; Lemos V; Katsyuba E; Jha P; Vijgen S; Rubbia-Brandt L; Kim YK; Kim JT; Kim KS; Shong M; Schoonjans K; Auwerx J
    J Hepatol; 2017 Jan; 66(1):132-141. PubMed ID: 27663419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puerarin protects against CCl4-induced liver fibrosis in mice: possible role of PARP-1 inhibition.
    Wang S; Shi XL; Feng M; Wang X; Zhang ZH; Zhao X; Han B; Ma HC; Dai B; Ding YT
    Int Immunopharmacol; 2016 Sep; 38():238-45. PubMed ID: 27318789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitigative effects of the bioactive flavonol fisetin on high-fat/high-sucrose induced nonalcoholic fatty liver disease in rats.
    Gaballah HH; El-Horany HE; Helal DS
    J Cell Biochem; 2019 Aug; 120(8):12762-12774. PubMed ID: 30861601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS.
    Song HM; Li X; Liu YY; Lu WP; Cui ZH; Zhou L; Yao D; Zhang HM
    Int J Mol Med; 2018 Jul; 42(1):193-207. PubMed ID: 29620148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates insulin resistance and hepatic steatosis via PI3K/Akt/GSK3β pathway.
    Zheng X; Zhao MG; Jiang CH; Sheng XP; Yang HM; Liu Y; Yao XM; Zhang J; Yin ZQ
    Phytomedicine; 2020 Jan; 66():153130. PubMed ID: 31790897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice.
    Feng Z; Pang L; Chen S; Pang X; Huang Y; Qiao Q; Wang Y; Vonglorkham S; Huang Q; Lin X; Wei J
    Int Immunopharmacol; 2020 Nov; 88():107003. PubMed ID: 33182043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR.
    Zhang CY; Tan XH; Yang HH; Jin L; Hong JR; Zhou Y; Huang XT
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Puerarin protects pancreatic β-cell survival via PI3K/Akt signaling pathway.
    Li Z; Shangguan Z; Liu Y; Wang J; Li X; Yang S; Liu S
    J Mol Endocrinol; 2014 Aug; 53(1):71-9. PubMed ID: 24827001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A botanical dietary supplement from white peony and licorice attenuates nonalcoholic fatty liver disease by modulating gut microbiota and reducing inflammation.
    Chen L; Kan J; Zheng N; Li B; Hong Y; Yan J; Tao X; Wu G; Ma J; Zhu W; Sheng L; Chen L; Li B; Zhong J; Du J; Li H
    Phytomedicine; 2021 Oct; 91():153693. PubMed ID: 34403877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats.
    Fan H; Ma X; Lin P; Kang Q; Zhao Z; Wang L; Sun D; Cheng J; Li Y
    Med Sci Monit; 2017 Nov; 23():5599-5612. PubMed ID: 29172017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Puerarin inhibits expression of tissue factor induced by oxidative low-density lipoprotein through activating the PI3K/Akt/eNOS pathway and inhibiting activation of ERK1/2 and NF-κB.
    Deng HF; Wang XL; Sun H; Xiao XZ
    Life Sci; 2017 Dec; 191():115-121. PubMed ID: 29037842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Puerarin stimulates proliferation and differentiation and protects against cell death in human osteoblastic MG-63 cells via ER-dependent MEK/ERK and PI3K/Akt activation.
    Wang Y; Wang WL; Xie WL; Li LZ; Sun J; Sun WJ; Gong HY
    Phytomedicine; 2013 Jul; 20(10):787-96. PubMed ID: 23639192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin ameliorates dysregulation of lipid metabolism genes via the PI3K/AKT pathway in a diet-induced mouse model of nonalcoholic fatty liver disease.
    Pisonero-Vaquero S; Martínez-Ferreras Á; García-Mediavilla MV; Martínez-Flórez S; Fernández A; Benet M; Olcoz JL; Jover R; González-Gallego J; Sánchez-Campos S
    Mol Nutr Food Res; 2015 May; 59(5):879-93. PubMed ID: 25712622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracts from Aralia elata (Miq) Seem alleviate hepatosteatosis via improving hepatic insulin sensitivity.
    Hwang KA; Hwang YJ; Kim GR; Choe JS
    BMC Complement Altern Med; 2015 Oct; 15():347. PubMed ID: 26438035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puerarin suppresses the hepatic gluconeogenesis via activation of PI3K/Akt signaling pathway in diabetic rats and HepG
    Liu Y; Qiu Y; Chen Q; Han X; Cai M; Hao L
    Biomed Pharmacother; 2021 May; 137():111325. PubMed ID: 33761593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Attenuated Hepatic Triglyceride Accumulation in Alcoholic Fatty Liver Disease in Mice.
    Huang S; Zhang B; Chen Y; Liu H; Liu Y; Li X; Bao Z; Song Z; Wang Z
    J Pharmacol Exp Ther; 2018 Mar; 364(3):452-461. PubMed ID: 29317476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Puerarin attenuates glucocorticoid-induced apoptosis of hFOB1.19 cells through the JNK- and Akt-mediated mitochondrial apoptotic pathways.
    Yu D; Mu S; Zhao D; Wang G; Chen Z; Ren H; Fu Q
    Int J Mol Med; 2015 Aug; 36(2):345-54. PubMed ID: 26101183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.
    Cai CX; Buddha H; Castelino-Prabhu S; Zhang Z; Britton RS; Bacon BR; Neuschwander-Tetri BA
    Dig Dis Sci; 2017 Apr; 62(4):968-978. PubMed ID: 28194671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.